Qiming Venture Partners is a leading China-based venture capital firm founded in 2006 by Duane Kuang and Gary Rieschel, headquartered in Shanghai with additional offices in Beijing, Suzhou, Hong Kong, Singapore, and a U.S. affiliate (Qiming Venture Partners USA) in Seattle, Washington. The firm invests at the early and growth stages, with roughly 70% of its investments concentrated in Series A and Series B rounds, across two core practice areas: Technology (mobile internet, consumer, AI, robotics, semiconductors, enterprise software, autonomous driving) and Healthcare (biotech, pharmaceuticals, medical devices, diagnostics, and digital health). Qiming manages 11 U.S. Dollar funds and 7 RMB funds with approximately $9.5 billion in capital raised, and has backed more than 580 companies, of which over 210 have exited via IPO on the NYSE, NASDAQ, HKEX, Shanghai, or Shenzhen exchanges, or through M&A. It is an early backer of some of China's most influential technology companies, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, Insta360, and Zhipu AI (Z.ai), alongside a deep healthcare portfolio spanning Zai Lab, Gan & Lee Pharmaceuticals, CanSino Biologics, Tigermed, and Insilico Medicine.
Every Qiming company that ships an API, scored the way a machine reads it — and why a competent China deep-tech book publishes APIs but has not yet operationalized trust.
Read the report$750.00 · every API-bearing company in the book, scored on the Kin Score
Portfolio Strengthacross 373 profiled portfolio companies on the network
Firms are ranked by cumulative portfolio strength — how many highly-rated API companies they've backed, weighted by tier across composite quality and agent-readiness. The averages below are a secondary read on the typical company in the book.
Qiming Venture Partners has 374 portfolio companies tracked on the APIs.io network, of which 374 (100%) publish APIs indexed here.
Its highest-rated API providers on the network are xiaoman, swap, StepFun, Unisound, liesheng.
Portfolio on the Network
Portfolio companies that publish APIs indexed on APIs.io, grouped by their
API Evangelist rating. Exemplar and Strong are expanded by default.
The 373 portfolio companies with APIs in the catalog, backed by
Qiming Venture Partners, scored on the Kin Score. Every figure below is computed from
the catalog — nothing here is written.
A facet is averaged over the members that carry it, not over the whole cohort — the
“Scored” column is that count. Averaging an absent facet as zero would score our own
coverage gaps as the providers’ posture.
What this cohort publishes
Artifact
This cohort
Catalog
Difference
MCP server (any)
6%
16%
-10
MCP server (first-party)
2%
7%
-5
Agent Skills
0%
0%
0
OAuth scopes
1%
9%
-8
Security
83%
88%
-5
Arazzo workflows
0%
2%
-2
Governance rules
0%
13%
-13
mcp_pct counts any mcp/ artifact including ones API Evangelist derived from the provider OpenAPI; mcp_first_party_pct counts only servers the provider publishes. Prefer the latter.
This roster declares 374 members; 373
resolve to a provider in the catalog and 373 carry a score
(100%). The figures above describe the scored members only.Generated from the catalog build of
25 August 2026, across 26891
providers, using the same computation served by the
APIs.io cohort API. Briefs are published for rosters of
5 or more scored providers; below that a distribution is not meaningful.
aid: qiming
name: Qiming Venture Partners
description: >-
Qiming Venture Partners is a leading China-based venture capital firm founded in 2006 by Duane Kuang
and Gary Rieschel, headquartered in Shanghai with additional offices in Beijing, Suzhou, Hong Kong,
Singapore, and a U.S. affiliate (Qiming Venture Partners USA) in Seattle, Washington. The firm invests
at the early and growth stages, with roughly 70% of its investments concentrated in Series A and Series B
rounds, across two core practice areas: Technology (mobile internet, consumer, AI, robotics,
semiconductors, enterprise software, autonomous driving) and Healthcare (biotech, pharmaceuticals,
medical devices, diagnostics, and digital health). Qiming manages 11 U.S. Dollar funds and 7 RMB funds
with approximately $9.5 billion in capital raised, and has backed more than 580 companies, of which over
210 have exited via IPO on the NYSE, NASDAQ, HKEX, Shanghai, or Shenzhen exchanges, or through M&A. It is
an early backer of some of China's most influential technology companies, including Xiaomi, Meituan,
Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, Insta360, and Zhipu AI (Z.ai), alongside a
deep healthcare portfolio spanning Zai Lab, Gan & Lee Pharmaceuticals, CanSino Biologics, Tigermed, and
Insilico Medicine.
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source: []
generated: '2026-07-22'
method: derived
image: https://www.qimingvc.com/favicon.ico
x-type: venture-capital
x-category: Venture Capital
created: '2026-07-17'
modified: '2026-07-17'
specificationVersion: '0.23'
tags:
- Venture Capital
- Seed
- Series A
- Series B
- Growth Equity
- Technology
- Healthcare
- Artificial Intelligence
- Semiconductors
- Robotics
- Biotech
- China
- Asia
apis: []
common:
- type: Website
url: https://www.qimingvc.com/en
- type: Portfolio
url: https://www.qimingvc.com/en/portfolio
- type: Portfolio
url: portfolio/qiming-portfolio.yml
- type: Team
url: https://www.qimingvc.com/en/team
- type: Team
url: team/qiming-team.yml
- type: InvestmentThesis
url: https://www.qimingvc.com/en/about
- type: News
url: https://www.qimingvc.com/en/newsroom
- type: Jobs
url: https://www.qimingvc.com/en/careers
- type: Pitch
url: mailto:BP@qimingvc.com
- type: Contact
url: mailto:contactus@qimingvc.com
- type: Crunchbase
url: https://www.crunchbase.com/organization/qiming-venture-partners
- type: LinkedIn
url: https://www.linkedin.com/company/qiming-venture-partners
- type: Twitter
url: https://twitter.com/QimingVC
- type: Features
data:
- "Stage: Early and growth stage; ~70% in Series A / Series B"
- "Sectors: Technology (mobile internet, consumer, AI, robotics, semiconductors, enterprise software, autonomous driving) and Healthcare (biotech, pharmaceuticals, medical devices, diagnostics, digital health)"
- "Geography: Greater China, with a U.S. affiliate in Seattle"
- "Capital raised: ~$9.5B across 11 USD funds and 7 RMB funds"
- "Portfolio: 580+ companies, 210+ IPO exits"
- "Founded: 2006"
- "HQ: Shanghai, China (offices in Beijing, Suzhou, Hong Kong, Singapore, Seattle)"
sources:
- https://www.qimingvc.com/en/about
- https://en.wikipedia.org/wiki/Qiming_Venture_Partners
updated: '2026-07-17'
maintainers:
- FN: Kin Lane
email: info@apievangelist.com
url: https://apievangelist.com
- FN: APIs.json
url: http://apisjson.org
- FN: Qiming Venture Partners
url: https://www.qimingvc.com/en
